INTERFERON-GAMMA TREATMENT FOR CERVICAL INTRAEPITHELIAL NEOPLASIA

被引:25
作者
IWASAKA, T
HAYASHI, Y
YOKOYAMA, M
HACHISUGA, T
SUGIMORI, H
机构
[1] Department of Obstetrics and Gynecology, Saga Medical School, Saga
关键词
D O I
10.1016/0090-8258(90)90316-D
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Eight patients with cervical intraepithelial neoplasia (CIN) were administered perilesional injections of human recombinant interferon γ (IFN-γ), and the response was evaluated by colposcopy and exfoliative cytology and then by histopathology. In all patients, colposcopic and cytologic findings improved after two to four injections of IFN-γ and the cytologic findings reverted to normal in five of these eight patients. All five were free of dysplastic lesions. The other three patients with positive cytology and positive colposcopy after completion of IFN-γ treatment underwent hysterectomy or laser conization, and histopathologic examination revealed residual dysplastic lesions. On the other hand, a control study revealed that only one of eight patients showed spontaneous regression during the 3-month observation period. During the course of these treatments, keratinizing cells were often present in the cervical smears and isolated cell keratinization was often evident in the residual dysplastic lesions of the surgical specimens. These observations suggest that IFN-γ treatment is an effective therapeutic method for CIN lesions and that IFN-γ has the potential to differentiate nonkeratinizing squamous cells into keratinizing cells. © 1990.
引用
收藏
页码:96 / 102
页数:7
相关论文
共 11 条
[1]   PURIFIED HUMAN IMMUNE INTERFERON HAS MORE POTENT ANTICELLULAR ACTIVITY THAN FIBROBLAST OR LEUKOCYTE INTERFERON [J].
BLALOCK, JE ;
GEORGIADES, JA ;
LANGFORD, MP ;
JOHNSON, HM .
CELLULAR IMMUNOLOGY, 1980, 49 (02) :390-394
[2]  
CHOO YC, 1986, BRIT J OBSTET GYNAEC, V93, P372
[3]   CLINICAL-TRIALS WITH EXOGENOUS INTERFERON - SUMMARY OF A MEETING [J].
DUNNICK, JK ;
GALASSO, GJ .
JOURNAL OF INFECTIOUS DISEASES, 1979, 139 (01) :109-122
[4]  
FLEISCHMANN WR, 1982, CANCER RES, V42, P869
[5]  
HSU C, 1984, ACTA CYTOL, V28, P111
[6]   INTERFERON TREATMENT OF UTERINE CERVICAL PRECANCEROSIS [J].
IKIC, D ;
SINGER, Z ;
BECK, M ;
SOOS, E ;
SIPS, D ;
JUSIC, D .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1981, 101 (03) :303-308
[7]  
Iwasaka T, 1986, Asia Oceania J Obstet Gynaecol, V12, P549
[8]   ANTITUMOR ACTIVITIES OF HUMAN RECOMBINANT INTERFERON-GAMMA AGAINST CERVICAL TUMOR TRANSPLANTED INTO NUDE-MICE [J].
IWASAKA, T ;
TSUGITOMI, H ;
OHKUMA, Y ;
YOSHIMURA, T ;
SUGIMORI, H .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1987, 66 (06) :501-505
[9]  
IWASAKA T, 1987, ACTA CYTOL, V31, P941
[10]  
STEWART WE, 1979, INTERFERON SYSTEM, P223